Richards Timothy T. sold $66K of CLPT
Richards Timothy T. sold 5,415 shares of ClearPoint Neuro, Inc. (CLPT) at $12.17 on 2026-06-01.
How this was made
The 30-second read
Why it matters
Insider selling can influence retail sentiment, but without additional company-specific developments, the trading signal is typically weak.
Market read
A new Form 4 reports an insider open-market sale at $12.17, offering limited incremental information for trading decisions.
What to watch
No context on total insider holdings over time, whether other insiders sold/bought, or whether the sale was part of a broader pattern; also no 10b5-1 plan is stated.
Background
The article is an SEC Form 4 insider transaction disclosure for ClearPoint Neuro, Inc. (CLPT).
Ticker impact
ClearPoint Neuro director Timothy T. Richards sold 5,415 shares at $12.17 on 2026-06-01, per a new SEC Form 4 filed 2026-06-02.
Likely limited, short-lived sentiment impact; no clear directional signal beyond typical insider-selling noise.
The filing is a primary-source Form 4, but the article provides only the sale size and price, with no accompanying company news, guidance, or material corporate event.
Market effects
No sector read-through is provided; this appears company-specific insider activity only.
None indicated.
None indicated.
Counterpoint
The sale may be for diversification, taxes, or pre-existing personal liquidity needs, so it may not reflect negative company fundamentals.
Key entities
- issuerClearPoint Neuro, Inc.
Company whose director sold shares, disclosed via SEC Form 4.
- insiderTimothy T. Richards
Director who executed an open-market sale of 5,415 shares.